Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide for Liver Volume in ADPKD
NCT02119052Phase 3Completed
- Sponsor
- University of Naples Federico II
- Start
- Jan 2009
- Primary completion
- Sep 2013
- Modality
- Peptides
01
Overview
Phase 3, randomised, double-blind trial of octreotide in Polycystic liver disease (PLD), sponsored by University of Naples Federico II. Primary endpoint: Effect of somatostatin on liver volume at 3 years. Started Jan 2009; status: completed.
02
Drugs
octreotide
03
Conditions
Polycystic liver disease (PLD)
Beyond the preview
Go deeper on NCT02119052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02119052.